Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

A Non-Invasive Technique which Demonstrates the Iron in the Buccal Mucosa of Sickle Cell Anaemia and Thalassaemia Patients who Undergo Repeated Blood Transfusions.

Chittamsetty H, Sekhar MS, Ahmed SA, Suri C, Palla S, Venkatesh SM, Tanveer S.

J Clin Diagn Res. 2013 Jun;7(6):1219-22. doi: 10.7860/JCDR/2013/5551.3084. Epub 2013 Apr 27.

2.

Buccal Mucosa Exfoliative Cell Prussian Blue Stain Co-Relates with Iron Overload in β-Thalassemia Major Patients.

Gajaria PK, Maheshwari UM, Borkar DB, Dhar R, Pancholi V.

Indian J Hematol Blood Transfus. 2017 Dec;33(4):559-564. doi: 10.1007/s12288-017-0801-4. Epub 2017 Mar 21.

PMID:
29075069
3.

Oral exfoliative cytology as a screening tool for iron overload in β-thalassemia patients.

Rathore AS, Keshri N, Shetty DC, Juneja S.

Int J Appl Basic Med Res. 2016 Jan-Mar;6(1):28-30. doi: 10.4103/2229-516X.174005.

4.

Estimation of iron overloads using oral exfoliative cytology in beta-thalassemia major patients.

Leekha S, Nayar AK, Bakshi P, Sharma A, Parhar S, Soni S.

Cytojournal. 2016 Mar 18;13:6. doi: 10.4103/1742-6413.178993. eCollection 2016.

5.

Demonstration of iron in exfoliated buccal cells of β-thalassemia major patients.

Bhat AA, Parwani RN, Wanjari SP.

J Cytol. 2013 Jul;30(3):169-73. doi: 10.4103/0970-9371.117662.

6.

Logarithmic quantitation model using serum ferritin to estimate iron overload in secondary haemochromatosis.

Güngör T, Rohrbach E, Solem E, Kaltwasser JP, Kornhuber B.

Arch Dis Child. 1996 Apr;74(4):323-7.

7.

Iron overload in Beta thalassaemia major and intermedia patients.

Mishra AK, Tiwari A.

Maedica (Buchar). 2013 Sep;8(4):328-32.

8.

Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.

Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A, Loutradi A, Loukopoulos D.

Br J Haematol. 2004 Sep;126(5):736-42.

PMID:
15327528
9.

Transfusion support for haemoglobinopathies.

Greenwalt TJ, Zelenski KR.

Clin Haematol. 1984 Feb;13(1):151-65. Review.

10.

Zinc supplements for treating thalassaemia and sickle cell disease.

Swe KM, Abas AB, Bhardwaj A, Barua A, Nair NS.

Cochrane Database Syst Rev. 2013 Jun 28;(6):CD009415. doi: 10.1002/14651858.CD009415.pub2. Review.

PMID:
23807756
11.

Effect of iron salts, haemosiderins, and chelating agents on the lymphocytes of a thalassaemia patient without chelation therapy as measured in the comet assay.

Anderson D, Yardley-Jones A, Vives-Bauza C, Chua-Anusorn W, Cole C, Webb J.

Teratog Carcinog Mutagen. 2000;20(5):251-64.

PMID:
10992272
12.

Acute splenic sequestration in female children with sickle cell disease in the North of Jordan.

Al-Rimawi HS, Abdul-Qader M, Jallad MF, Amarin ZO.

J Trop Pediatr. 2006 Dec;52(6):416-20. Epub 2006 Sep 2.

PMID:
16951418
13.

Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation.

McLeod C, Fleeman N, Kirkham J, Bagust A, Boland A, Chu P, Dickson R, Dundar Y, Greenhalgh J, Modell B, Olujohungbe A, Telfer P, Walley T.

Health Technol Assess. 2009 Jan;13(1):iii-iv, ix-xi, 1-121. doi: 10.3310/hta13010. Review.

14.

[Iron overload in sickle cell anemia : a study of 94 patients].

Hafsia R, Belakhal F, Ben Salah N, Gouider E, Elborgi W.

Tunis Med. 2011 Jun;89(6):548-52. French.

15.
16.

Alpha thalassemia among sickle cell anaemia patients in Kampala, Uganda.

Lubega I, Ndugwa CM, Mworozi EA, Tumwine JK.

Afr Health Sci. 2015 Jun;15(2):682-9. doi: 10.4314/ahs.v15i2.48.

17.

No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.

Ghoti H, Goitein O, Koren A, Levin C, Kushnir T, Rachmilewitz E, Konen E.

Eur J Haematol. 2010 Jan 1;84(1):59-63. doi: 10.1111/j.1600-0609.2009.01355.x. Epub 2009 Sep 29.

PMID:
19793250
18.

Genetic Blood Disorders Survey in the Sultanate of Oman.

Al-Riyami A, Ebrahim GJ.

J Trop Pediatr. 2003 Jul;49 Suppl 1:i1-20.

PMID:
12934793
19.

Iron overload and glucose metabolism in subjects with β-thalassaemia major: an overview.

De Sanctis V, Soliman A, Yassin M.

Curr Diabetes Rev. 2013 Jul;9(4):332-41. Review.

PMID:
23687960
20.

Pancreatic iron loading in chronically transfused sickle cell disease is lower than in thalassaemia major.

Noetzli LJ, Coates TD, Wood JC.

Br J Haematol. 2011 Jan;152(2):229-33. doi: 10.1111/j.1365-2141.2010.08476.x. Epub 2010 Dec 1.

PMID:
21118197

Supplemental Content

Support Center